Methyl p‐hydroxybenzoate (E‐218) a preservative for drugs and food is an activator of the ryanodine receptor Ca 2+ release channel
Haloperidol is a drug used in the management of several psychotic disorders and its use has been linked to Neuroleptic Malignant Syndrome. In the present study we have investigated the effect of a commercial preparation of haloperidol, Serenase, on skeletal muscle sarcoplasmic reticulum. Addition of...
Gespeichert in:
Veröffentlicht in: | British journal of pharmacology 2009-01, Vol.131 (2), p.335-341 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Haloperidol is a drug used in the management of several psychotic disorders and its use has been linked to Neuroleptic Malignant Syndrome. In the present study we have investigated the effect of a commercial preparation of haloperidol, Serenase, on skeletal muscle sarcoplasmic reticulum.
Addition of Serenase to isolated terminal cisternae caused a rapid release of calcium. We tested whether the active Ca
2+
‐releasing substance was haloperidol or another compound present in the preparation.
Our results show that methyl p‐hydroxybenzoate, one of the preservatives and a commonly used anti‐microbial agent (E‐218) is an activator of Ca
2+
release (E.C.50=2.0 m
M
), mediated by a ruthenium red‐sensitive Ca
2+
release channel present in skeletal muscle terminal cisternae.
British Journal of Pharmacology
(2000)
131
, 335–341; doi:
10.1038/sj.bjp.0703571 |
---|---|
ISSN: | 0007-1188 1476-5381 |
DOI: | 10.1038/sj.bjp.0703571 |